This new article publication from Acta Pharmaceutica Sinica B, discusses how a novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A.
Oleanolic acid shows promise as an adjunct therapy for overcoming sorafenib resistance in HCC. By reducing cell aggressiveness and restoring drug sensitivity, OA may enhance the therapeutic efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results